
    
      The main purpose of this study is to:

        -  Evaluate the safety of vorinostat in combination with sorafenib.

        -  Determine the largest dose of vorinostat + sorafenib that can be given safely to humans.

        -  Determine if vorinostat + sorafenib are effective in stopping tumors from growing or in
           decreasing their size.

        -  Study the side effects of vorinostat + sorafenib.
    
  